E-cigarette usage is increasing, especially among the young, with both the general population and physicians perceiving them as a safe alternative to tobacco smoking. Worryingly, e-cigarettes are commonly used by pregnant women. As nicotine is known to adversely affect children in utero, we hypothesized that nicotine delivered via e-cigarettes would negatively affect lung development. To test this, we developed a mouse model of maternal e-vapor (nicotine and nicotinefree) exposure and investigated the impact on the growth and lung inflammation in both offspring and mothers. Female Balb/c mice were exposed to e-fluid vapor containing nicotine (18 mg/ml nicotine E-cigarette [E-cig18], equivalent to two cigarettes per treatment, twice daily,) or nicotine free (E-cig0 mg/ml) from 6 weeks before mating until pups weaned. Male offspring were studied at Postnatal Day (P) 1, P20, and at 13 weeks. The mothers were studied when the pups weaned. In the mothers' lungs, e-cigarette exposure with and without nicotine increased the proinflammatory cytokines IL-1b, IL-6, and TNF-a. In adult offspring, TNF-a protein levels were increased in both E-cig18 and E-cig0 groups, whereas IL-1b was suppressed. This was accompanied by global changes in DNA methylation. In this study, we found that e-cigarette exposure during pregnancy adversely affected maternal and offspring lung health. As this occurred with both nicotine-free and nicotine-containing e-vapor, the effects are likely due to by-products of vaporization rather than nicotine.
Tobacco cigarette smoking during pregnancy is well known to be deleterious to respiratory health for both the mother and unborn child. Smoking is well known to increase the risk of both bacterial and viral infection (1) and, although little evidence exists, at least similar effects would be expected in pregnancy. Similarly, maternal tobacco smoke exposure leads to increased risk of recurrent wheeze, development of asthma, bronchitis, and hospitalization for respiratory infections, and a lifelong decrease in pulmonary function for the offspring (reviewed in Reference 2).
Recent studies have suggested that maternal smoking also predisposes to the development of chronic obstructive pulmonary disease (COPD) (3) . Nicotine delivered in cigarettes is well known to contribute to the detrimental effects of maternal tobacco smoking on offspring lung development, leading to the suggestion that nicotine delivered by e-cigarette use would be similarly deleterious (4) . However, it is important to note that e-cigarettes deliver more than just nicotine.
Advertised as a safe alternative to tobacco cigarettes, e-cigarettes have rapidly infiltrated the market since their first appearance in 2004. E-cigarette sales continue to increase, with sales in traditional retail stores in the United States doubling between 2012 and 2013, equating to over $600 million in sales (5) . Approximately 5% of adults in the United States are current users, with the highest prevalence in young adults (18-34 yr old) (6) . E-cigarette use among adolescents has also increased dramatically since 2011, with an estimated 3 million middle and high school student users in 2015 (7) . E-cigarettes administer nicotine as a vapor and do not require tobacco combustion, and are therefore assumed to remove the risks associated with tobacco cigarettes. However, numerous studies have reported the presence of toxic compounds in e-cigarette aerosol (8) and deleterious effects on a variety of cells in vitro (9) (10) (11) . Despite the rising use of e-cigarettes and the potential risks, little is known as to the effect of e-cigarettes in utero.
Pregnant women may be particularly drawn to advertising campaigns that suggest e-cigarettes as a "safe" alternative to tobacco cigarettes. This opinion is echoed by the medical community; for example, members of the American College of Obstetricians and Gynecologists consider e-cigarettes safer than tobacco cigarettes. Indeed, recent evidence also suggests that most pregnant women perceive e-cigarettes as a safer alternative to tobacco cigarettes (12, 13) . Currently, the use of e-cigarettes during pregnancy appears similar to tobacco cigarette smoking, with up to 15% of pregnant women using e-cigarettes (12) . Taken together with data suggesting increased use among women of childbearing age (6) , these studies reinforce the importance of determining the potential respiratory toxicity of e-cigarette use during pregnancy.
The development of asthma and COPD is associated with a variety of intrauterine exposures, such as cigarette smoke. Such predisposition to lung disease is thought to be due to abnormal regulation of the inflammatory environment and/or physical changes to the lung structure. Both asthma and COPD are chronic inflammatory diseases of the airways, and have traditionally been distinguished by the pattern, or phenotype, of airway inflammation. Early-onset asthma is typically characterized by allergic eosinophilic inflammation (typified via increased IL-4, IL-5, and IL-13), whereas COPD is associated with nonallergic inflammation (for example, increases in IL-6, IL-1b, and TNF-a), although there exists overlap in inflammatory profiles between asthma and COPD (14) . Numerous growth factors, such as secretoglobin 1a1 (or Clara cell secretory protein) or any of the surfactant-associated , and TNF-a (C) in the mothers' lung. Results are expressed as mean (6SEM). In the representative gel images, all samples were run on the same gel but rearranged to correspond to the graph layout. *P , 0.05, **P , 0.01 versus sham (n = 6), † P , 0.05 versus E-cig18. e-cig0 = 0 mg/ml nicotine E-cigarette; e-cig18 = 18 mg/ml nicotine E-cigarette.
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protein genes (Sfpta, Sfptb, Sfptc) are important in determining the fate of airway and alveolar cells (15) . Moreover, in utero changes in growth factors, such as platelet-derived growth factor a (PDGFa) (16) , or receptors, such as the ephrin type-B receptor 2, effects alveolarization (17) , and thus may contribute to the development and severity of future lung diseases.
Because E-cigarettes are potentially deleterious to the respiratory health of the developing lung in vitro, the aim of the present study was to examine the potential effects of e-cigarettes in a mouse 
E-Cigarette Exposure and Study Design
After 1 week of acclimatization, 7-week-old female mice were randomized into three groups for exposure: room air (sham); e-cigarette liquid without nicotine (E-cig0); and e-cigarette liquid containing 18 mg/ml nicotine (E-cig18). Both e-cigarette liquids contained 50% propylene glycol/50% vegetable glycerine and tobacco flavor additives (Vaper Empire). Only female breeders were exposed, with male breeders and offspring remaining in their home cages during exposure. For exposure, female mice were removed from their cages and placed in a custom designed 9L chamber filled with the e-cigarette fluid aerosols twice daily (2 3 15-min exposures with a 5-min washout interval, equivalent nicotine exposure to two tobacco cigarettes twice daily). At the end of the exposure protocol, mice were returned to their cages. E-cigarette fluid aerosols were generated by an e-cigarette device (KangerTech NEBOX). Adult mice were exposed for 6 weeks before gestation; during gestation and lactation (up to Postnatal Day [P] 20), pups were never directly exposed. The vapor was generated using 4 3 5-second activations at 30 Watts for each exposure, with a 20-second interval between each vaping to prevent overheating of the coil. The nicotine dose was adopted from our previous studies on the effect of maternal cigarette smoke exposure on offspring health (18, 19) . Sham-exposed mice were treated exactly the same, but exposed to room air and not e-cigarette vapor. Female breeders were killed when the pups weaned at P20. Male offspring were killed at P1, P20, and 13 weeks. Liver, retroperitoneal fat, epididymal fat was 
ORIGINAL RESEARCH
harvested and weighed from the mothers and offspring. The lung was harvested from female breeders and offspring, snap frozen, and stored at 280 8 C for mRNA and protein analyses. Blood from P20 offspring was collected via cardiac puncture after deep anesthesia (4% isoflurane, 1% O 2 ) and cotinine measured in the plasma using an ELISA kit (Abnova, Taipei, Taiwan) per the manufacturer's instructions.
Real-Time PCR mRNA was analyzed using preoptimized and validated TaqMan primers and probes (Thermo Fisher Scientific; Table 1 ). See the data supplement for full methods.
Western Blotting
The protein levels of extracellular signalregulated kinases (ERKs) 1/2, c-Jun N-terminal kinases (JNK), p38, p65, IL-1b, IL-6, and TNF-a were measured by Western blotting. See the data supplement for full methods.
Global DNA Methylation Assay
A 5-methyl Cytosine kit (Zymo Research) was used to assess global DNA methylation levels in the lung from the offspring at P1 (n = 3). See the data supplement for full methods.
Statistical Analysis
Results are expressed as mean (6SEM) and analyzed by one-way ANOVA followed by Fisher's least significant diffierence post hoc tests (Statistica 10; Statsoft Inc.). A P value less than 0.05 was considered as the threshold for statistical significance.
Results

The Effect of E-Cigarette Exposure on the Mothers
Anthropometry markers. Weight gain can be used as a global indication of health status in animal models. After the first 6 weeks of exposure, mothers exposed to room air (control) and mothers exposed to E-cig18 had similar weight gain (1.50 6 0.33 g and 1.49 6 0.20 g, respectively)
. Surprisingly, the mothers exposed to E-cig0 only had one-third the weight gain of the sham group (0.46 6 0.39 g). When offspring were weaned, there was no difference in weight gain of the mothers between the three exposure groups (sham, 6.43 6 0.57 g; E-cig0, 6.95 6 0.50 g; E-cig18, 5.66 6 0.79 g). Similarly, liver weight did not differ between the three groups (expressed as % body weight: control, 5.93 6 0.22%; E-cig18, 6.69 6 0.28%; E-cig0, 6.74 6 0.37%). However, compared with the control group (expressed as % body weight: 0.30 6 0.04%), retroperitoneal fat mass was significantly reduced in both the E-cig18 (0.18 6 0.02%) and E-cig0 (0.16 6 0.002%) mothers (P , 0.05 for both). Lung inflammatory markers. To determine the effect of e-cigarette exposure on the lung inflammatory environment, we measured proinflammatory cytokine protein levels in the lungs of mothers. IL-1b protein was increased in E-cig18 dams compared with both control and E-cig0 dams (P , 0.01 and P , 0.05, respectively; Figure 1A ). There was no difference in IL-1b protein between control and E-cig0 groups (P = 0.11). IL-6 protein level was increased in the E-cig0 dams (P , 0.05), but not the E-cig18 dams compared with control ( Figure 1B) . Compared with control, TNF-a protein level was more than tripled in both E-cig18 and E-cig0 dams (both P , 0.01; Figure 1C ).
Increased cytokine production can occur by several mechanisms, but the most common is activation of transcription factors leading to transcription and translation. To investigate if e-cigarette exposure was activating proinflammatory signaling, we measured the expression of various proinflammatory signaling molecules known to be involved IL-1b and IL-6 production ( Figure 2 ). Exposure to E-cig0 up-regulated total Erk1/2 and total JNK, whereas E-cig18 up-regulated only total JNK. Activation of ERK1/2 and JNK was assessed by measuring phosphorylated protein. E-cig0 increased phosphorylated (p)-JNK, but not p-Erk1/2. p38 and p65 NF-kB were not increased by either E-cig0 or E-cig18 in comparison to control animals.
The Effect of Maternal E-Cigarette Exposure on Offspring
Anthropometry markers. At P1, there was no difference in body weight or organ weight among the offspring groups (sham, E-cig0 and E-cig18 (Table 2) . At P20, E-cig0 offspring were heavier than both control and E-cig18 offspring (P , 0.05 and P , 0.01, respectively). E-cig18 offspring had reduced body weight compared with controls (P , 0.05). In contrast, liver weight, as a percentage of body weight, was increased in E-cig18 offspring compared with control (P , 0.01), but not in the E-cig0 offspring, suggesting that the effect was mediated by nicotine. Both E-cig0 and E-cig18 offspring had bigger retroperitoneal fat mass compared with control offspring (P , 0.05 for both), with E-cig0 having increased fat mass compared with E-cig18 (P , 0.05). Epididymal fat mass was only increased in E-cig0 compared with both control and E-cig18 offspring (P , 0.01 for both). At 13 weeks, there was no difference in body weight between the groups. However, liver weight in the E-cig0 offspring was reduced compared with both control and E-cig18 offspring (P , 0.05).
Retroperitoneal fat mass was increased in both E-cig18 and E-cig0 offspring compared with control (P , 0.05), whereas there was no difference in epididymal fast mass. As expected, blood cotinine levels were increased in E-cig18 offspring (9.12 6 1.17 ng/ml) at weaning compared with both control and E-cig0 offspring (2.83 6 0.63 and 3.31 6 0.57 ng/ml, respectively; n = 9-10; P , 0.01 for both versus E-cig18).
Lung-developmental markers in early life. To determine the potential effect of in utero e-cigarette exposure on lung development we measured markers of alveoli development by quantitative PCR. At P1, there was no difference in PDGF and ephrine B2 mRNA expression among the three groups ( Figures 3A and 3C ). At P20, PDGF mRNA levels were significantly upregulated in the E-cig18 and E-cig0 offspring compared with the control group (P , 0.05 for both; Figure 3b ). mRNA levels of surfactant protein C (Sftpc) were similar among the groups at both P1 and P20 ( Figures 3E and 3F) .
Lung Inflammatory Markers. To investigate if the effects of in utero ecigarette exposure on lung inflammatory homeostasis were different at adulthood, we measured the levels of proinflammatory cytokines. At 13 weeks of age, IL-1b protein levels were suppressed in the lung of both E-cig18 and E-cig0 offspring compared with control animals (both P , 0.01 versus sham; Figure 4A ). Although not significant, there was a trend for increased IL-6 in the E-cig0 group compared with the control group (P = 0.05), whereas there was no change in E-cig18 offspring ( Figure 4B ). In contrast, TNF-a protein levels were significantly increased in both E-cig18 and E-cig0 offspring compared with control animals (P , 0.01 for both; Figure 4C ).
We subsequently investigated the effect of maternal e-cigarette exposure on protein levels in lung homogenates of signaling pathways known to control inflammation ( Figure 5 ). Although neither maternal e-cigarette exposure altered Erk1/2 levels compared with the controls, there was an increase in Erk1/2 protein in E-cig0 offspring compared with E-cig18 offspring. When adjusted for total Erk1/2, p-Erk1/2 Figure 3 . mRNA expression of alveoli developmental markers platelet-derived growth factor (PDGF; A and B), ephrine B2 (EphB2; C and D), and surfactant protein C (Sftpc; E and F) in offspring's lung at Postnatal Day (P) 1 and P20. Results are expressed as mean (6SEM). **P , 0.01 versus sham (n = 6-8).
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was increased in E-cig18 mice compared with E-cig0 mice ( Figure 5C ). There were similarly disparate effects on JNK protein expression, with increased levels in E-cig18 mice (P , 0.05 versus control; Figure 5D ), but not E-cig0 mice, compared with controls. However, p-JNK protein and p-JNK adjusted for total protein were increased in mice exposed to E-cig0 compared with E-cig18 offspring (P , 0.05 for both). Compared with control, p38 expression was increased in both E-cig0 and E-cig18 mice (P , 0.01 versus control for both; Figure 5G ), and p-p38 was increased by only E-cig18, with similar ratios of total to p-p38 between the three groups ( Figure 5I ). There was no effect on total p65 of either maternal e-cigarette exposure. However, the phosphorylated form was halved in E-cig18 offspring (P , 0.05 versus controll Figure 5K ), suggesting altered NFkB activation, but was not effected by E-cig0 exposure. The ratio between phosphorylated and total p65 was significantly reduced in the E-cig18 offspring (P , 0.01 versus control; Figure 5L ).
Activation of Epigenetic Remodeling Events by Global DNA Methylation
DNA methylation is an important mechanism by which various genes can be controlled, with DNA hypermethylation (increased methylation) generally resulting in gene silencing. We assessed global DNA methylation in the lungs at P1, by measuring the amount of methylated cytosines (5 mC) in the sample relative to global cytidine (5 mC 1 dC). Compared with control offspring at P1, global methylation was more than tripled in E-cig0 offspring (P , 0.01 versus both E-cig18 and control) and more than doubled in E-cig18 offspring (P , 0.05 versus control) ( Figure 6 ). To complement these data, we also measured the mRNA expression of a range of inflammatory cytokines known to be elevated in people with asthma and/or COPD. We found that maternal e-cigarette exposure increased the expression of inflammatory cytokines in P1 lungs.
Interestingly, E-cig0, but not E-cig18, increased IL-5, IL-13, and TNF-a ( Figures  6B-6D ), whereas no changes were observed in IL-4, Il-1b, or IL-6 in either e-cigarette exposure group (Figures 6E-8G) .
Discussion E-cigarettes are often considered a safe alternative to tobacco smoking, but very little is known as to their potential toxicity, especially in susceptible populations, such as pregnant mothers and their unborn children. Therefore, we developed a mouse model to investigate the effects of intrauterine e-cigarette exposure to determine the effect on respiratory health in both mothers and offspring. Longterm E-cigarette exposure induced significant inflammatory responses in the mothers, and this was independent of the effect of nicotine.
In utero e-cigarette exposure had differential effects on the markers of lung development in early life. However, mice exposed to intrauterine e-cigarettes had altered homeostatic levels of several proinflammatory cytokines in adulthood, suggesting that e-cigarette exposure reprogrammed immune homeostasis. Surprisingly, our results suggest that these effects appear partially independent of nicotine. The adverse effect of tobacco smoking during pregnancy on offspring birth weights is well known and contributes to increased risk of numerous chronic diseases (20) . In the present study, in utero exposure to e-cigarette containing nicotine lowered birth weight (albeit not significantly), and led to reduced body weight at weaning. Surprisingly, offspring exposed to e-cigarette without nicotine in utero had increased fat mass at weaning compared with controls and in utero nicotine-exposed mice. This may be due to prioritization of maternal nutrients to suckling pups, as E-cig0 mothers had the least weight gain at weaning. At adulthood, there was no difference in fat mass between the e-cigarette offspring groups, but both groups had increased fat mass compared with control. Although the mechanisms for the increased fat mass are unknown, it may reflect abnormal metabolic function and have potential implications for the development of metabolic disorders. Figure 5 . Protein levels of factors involved in inflammatory signaling pathways in offspring's lungs at 13 weeks. (A-C) Erk1/2 (total and phosphorylated), (D-F) JNK (total and phosphorylated), (G-I) p38 (total and phosphorylated), and (J-L) NF-kB (total and phosphorylated). Results are expressed as mean (6SEM). In the representative gel images, all samples were run on the same gel but rearranged to correspond to the graph layout. *P , 0.05, **P , 0.01 versus sham; † P , 0.05, † † P , 0.01 versus E-cig18 (n = 7-8).
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It has been well accepted that tobacco smoke and nicotine exposure during prenatal and postnatal life can impair lung development (21) . Therefore, we measured mRNA levels of three markers important in lung development: PDGFa, EphB2, and Sftpc. E-cigarette exposure did not alter EphB2 and Sftpc. In contrast, PDGFa was increased in both e-cigarette exposure groups (i.e., with and without nicotine). Although the majority of the effect of in utero tobacco exposure on lung development is attributed to nicotine (22) , the increase in PDGFa in the present study suggests that either the e-cigarette humectants or flavor additives increased PDGFa mRNA expression. PDGF signaling is important to lung development, and elevated PDGF signaling has been linked to lung fibrosis (23) . Exposure to e-cigarette aerosol containing nicotine in the first 10 days of life has been shown to induce small increases in alveolar size in mice (24) . In this study, we measured selected markers of lung development, which does limit the generalizability of the findings to all aspects of lung development. To fully investigate the abnormality in lung development, other molecular markers or anatomical changes using careful stereotactic techniques should be performed.
The present findings suggest that e-cigarette exposure during pregnancy induces an abnormal inflammatory environment in the lung of both the mothers and offspring. Protein expression of IL-1b, IL-6, and TNF-a were all increased in the lungs of mothers, with the effect on IL-6 and TNF-a being independent of nicotine. A proinflammatory environment within the lung is consistent with previous findings reporting increased IL-6, MCP-1, IL-1a and b, IL-10, and IL-13 in BAL fluid of adult mice exposed to e-cigarettes containing nicotine and tobacco flavorings (10) . Similarly, exposure to e-cigarette vapor extract promotes proinflammatory responses from human neutrophils (25) and airway epithelial cells (10) . Importantly, effects in airway epithelial cells were also independent of nicotine. As seen in the mothers, TNF-a was also increased in the lungs of the offspring; however, in contrast to mothers, IL-1b was decreased in offspring exposed to e-cigarettes. This effect was independent of nicotine. Our findings also suggest that inflammatory signaling pathways are differentially altered in mothers and offspring, with changes in ERK1/2 and JNK expression seen in mothers, but changes in p38 and p65 in offspring. Taken together, these findings suggest that exposure to e-cigarettes induces immune dysregulation within the lung, and that the effect of in utero exposure can been seen in adulthood.
DNA methylation is a potential mechanism for the adverse impact of smoking during pregnancy on offspring health. Our findings suggest that in utero e-cigarette exposure leads to abnormalities in DNA methylation. Surprisingly, these effects appear to be independent of nicotine, because global DNA methylation was increased in mice exposed to e-cigarette vapor with and without nicotine.
In this study, we measured global DNA methylation to identify potential epigenetic changes due to e-cigarette exposure. We report that maternal exposure to both e-cigarettes containing nicotine and without nicotine led to increased DNA methylation in the lungs of offspring. However, these changes in global DNA methylation do not provide information as to which parts of the genome are epigenetically reprogrammed. Therefore, future studies should to be performed to identify site-specific methylation changes and their relationship to the potential consequences of e-cigarette use. Recent evidence suggests that thousands of CpGs are differentially methylated in newborns and older children who were exposed to tobacco smoke in utero (26) . These methylated sites corresponded to pathways ORIGINAL RESEARCH involved in anatomical development, protein kinase activity, and gene expression of proinflammatory cytokines. Taken together, these findings suggest that e-cigarette use during pregnancy is likely to induce epigenetic modifications in offspring that contribute to detrimental health outcomes. Our mouse model adequately reflects important aspects of e-cigarette use in humans, and thus provides important evidence for the effect of intrauterine e-cigarette exposure in humans. First, we chose to use a flavored e-cigarette, as research suggests that almost all users under 30 years of age and over one-half of adults use flavored e-cigarettes (27) . Tobacco flavor has been suggested to be particularly preferred by users (28) , especially in current and former tobacco smokers (29) . Second, serum cotinine levels in offspring of mothers exposed to E-cig18 in the present study (9.12 6 1.17 ng/ml) were similar to our findings in offspring of mothers exposed to tobacco cigarette smoke before gestation until weaning (19, 30) . It is also consistent with the blood level in human infants of smoking mothers (31) , suggesting that the model is sufficient to allow comparison with the effects of tobacco cigarette smoke. Although the effect of in utero exposure on offspring cotinine in humans is unknown, our model led to similar levels as those seen in adult human users after a single session (32) . Taken together, these observations suggest that our findings in the present mouse model likely reflect the potential for harm to human users and their unborn children after e-cigarette exposure.
The current study focused on the developmental and inflammatory aspects of maternal programming effects. Based on our previous studies in mouse models of maternal cigarette smoking, there is a significant sex difference. Male offspring are more susceptible to the effect of maternal smoking (delayed development and increased inflammatory responses in multiple organ systems). In future studies, we would like to directly study sex differences in the offspring, as well as look at differences in maternal versus paternal smoking.
This study has limitations that need to be considered. In developing a model of in utero e-cigarette exposure, we did not carry out mechanistic studies, have a tobacco exposure comparator group, use a range of e-cigarette exposure concentrations, or use several flavors of ecigarettes. These are perhaps design flaws in our study. Of these limitations, we think that the lack of different flavors is perhaps the greatest limitation. Different flavors are likely to decompose to different toxic compounds during vaporization; therefore, it is possible that different effects would be observed. However, we believe that, even though our study is limited by design and analysis, the results are alarming and require verification by other groups.
In conclusion, we report that, in a mouse model of e-cigarette exposure during pregnancy, both nicotine and nonnicotine constituents induce inflammatory responses in the lung of both mothers and offspring. Our findings suggest that different signaling pathways may be altered in mothers and offspring, and that epigenetic modifications are likely to contribute in offspring. Taken together, our study results suggest that e-cigarette use during pregnancy should not be considered safe for future lung health of the child. n
